Golden
Arsanis

Arsanis

A company developing targeted monoclonal antibody immunotherapies for the treatment of infectious diseases

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

April 2017

Arsanis raises a $45,500,000 series D round from Polaris Partners, NeoMed, GV, Anna Maria and Stephen Kellen Foundation, EMBL Ventures, SV Health Investors, Bill & Melinda Gates Foundation and OrbiMed.

September 3, 2013

Arsanis raises a $20,000,000 series B round from Polaris Partners.

February 28, 2011

Arsanis raises a $10,000,000 series A round from Polaris Partners.

People

Name
Role
LinkedIn

Albert Federico

Employee



Errik Anderson

Founder



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services